missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human DR5 Synthetic Peptide
Synthetic Peptide
Brand: Invitrogen™ PEP0021
Additional Details : Weight : 0.01000kg
Description
DR5 Synthetic Peptide, PEP-0021, from Invitrogen.
DR5 (Apo2, TRAIL-R2, TRICK2, KILLER) is a recently identified death domain containing receptor for TRAIL, which mediates TRAIL induced apoptosis. DR5 is a member of the TNF-receptor superfamily, and contains an intracellular death domain. DR5 can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces an apoptosis signal. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by DR5. Two transcript variants encoding different isoforms of DR5 and one non-coding transcript have been found. Overexpression of DR5 induces apoptosis and activates NF-kappa-B. DR5 is expressed in a number of cell types, and to particularly high levels in lymphocytes and spleen. Diseases associated with DR5 dysfunction include squamous cell carcinoma, and diffuse infiltrative lymphocytosis syndrome. This peptide corresponds to 20 amino acids near the carboxy terminus of human DR5.PEP-0021 can be used as a blocking peptide with polyclonal antibody PA5-19895.Specifications
8795 | |
purified | |
Human DR5 | |
-20°C | |
Liquid | |
Blocking Assay, Control | |
No | |
Peptide | |
RUO - research use only |
Human | |
O14763 | |
200 μg/mL | |
Synthetic Peptide | |
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 | |
TNFRSF10B | |
0.02% sodium azide | |
50 μg | |
PBS |